Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis

Gut Microbes, Год журнала: 2021, Номер 13(1)

Опубликована: Янв. 1, 2021

The gut bacterium

Язык: Английский

---

Challenges and opportunities in NASH drug development

Nature Medicine, Год журнала: 2023, Номер 29(3), С. 562 - 573

Опубликована: Март 1, 2023

Язык: Английский

---

Polystyrene microplastics induce hepatotoxicity and disrupt lipid metabolism in the liver organoids

The Science of The Total Environment, Год журнала: 2021, Номер 806, С. 150328 - 150328

Опубликована: Сен. 15, 2021

Язык: Английский

---

Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment

International Journal of Molecular Sciences, Год журнала: 2022, Номер 23(24), С. 15489 - 15489

Опубликована: Дек. 7, 2022

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic disease, affecting approximately one-quarter of global population, and has become a world public health issue. NAFLD clinicopathological syndrome characterized by hepatic steatosis, excluding ethanol other definite damage factors. Recent studies have shown that development associated with lipid accumulation, oxidative stress, endoplasmic reticulum lipotoxicity. A range natural products been reported as regulators in vivo vitro. This paper reviews pathogenesis some to therapeutic effects on NAFLD. Our work shows can be potential option for

Язык: Английский

---

Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease

Free Radical Biology and Medicine, Год журнала: 2019, Номер 144, С. 293 - 309

Опубликована: Май 29, 2019

Язык: Английский

---